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Background: Patients with severe COPD suffer from impairments of exercise capacity
which affects daily activity. Conversely, activity might exert effects on the functional
state. We studied whether a short-term intervention by regular phone calls caused an
increase in activity at home and whether this resulted in a gain in exercise capacity.
Methods: Over a 2-week period (P1) normal daily activity was assessed in 21 patients with
stable severe COPD (GOLD III/IV). After this, the individual setting was explored in a short
home visit. The subsequent 2-week period (P2) involved phone calls every other day to
raise home-based activity (target: 3 15min daily at 75% of maximum dyspnea). During
the study, patients wore an actograph plus pedometer and kept a diary. Before P1 and after
P2, 6-min walking distance (6MWD), lung function, the Borg score and quality of life
(SF-36, SGRQ) were determined.
Results: Compared to P1, actograph counts (po0.05) were higher in P2. There was also an
increase in 6MWD (po0.05) and quality of life scores (SF-36, po0.05) between initial and
final visit, whereby improvements in 6MWD correlated with changes in activity (po0.01).
Conversely, four patients who experienced an exacerbation in P2 showed no increase in
activity or 6MWD.
Conclusions: In patients with stable severe COPD, it was possible to increase activity by
regular phone calls without performing previous rehabilitation. Increased activity resultedElsevier Ltd. All rights reserved.
from the vffr Schleswig-Holstein and by the Deutsche Rentenversicherung Nord.
Outpatient Clinic for Occupational, Social and Environmental Medicine, Ludwig-Maximilians-University
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Intervention by phone calls 21in increased exercise capacity and quality of life within 2 weeks, underlining the
effectiveness of continued motivational support in patients with severe COPD.
& 2007 Elsevier Ltd. All rights reserved.Introduction
Patients with severe COPD suffer from limitations of their
exercise performance which can be quantified by, e.g.,
6-min walking distance (6MWD). Conversely, 6MWD and
analogous measures demonstrate the effectiveness of
exercise training.1–3 A multitude of programmes have been
used,4 comprising in-patient,5 out-patient,6,7 home-based
training,2 or their combination.8–10 Training can be inte-
grated in daily life and maintained over long periods of time,
and positive effects of rehabilitation and domiciliary activity
on the frequency of disease-related hospital admissions
have been described.9,11,12
The fact that improvements are achievable by moderate
exercise suggests that also small changes in daily activity
might have noticeable effects on performance. Obviously,
activity in patients with COPD is influenced by a host of
factors, including functional and psychosocial ones. Within
hospital-based settings, we found activity to be related to
6MWD13 and 6MWD to dyspnea,14 while both were not or
weakly associated with lung function. More importantly,
when patients participated in a short-term training pro-
gramme, there was excess activity beyond that representing
the training.13 This suggested motivation and self-reliance
to be relevant factors. It also raised the question whether
activity and exercise performance could be improved solely
by motivational means. One of the simplest interventions is
phone contact, and clinical experience suggests that
patients might well respond to signs of continued personal
care in this form.
Based on these considerations, the present study explored
whether in patients with severe COPD an intervention in
terms of regular phone calls would raise daily activity at
home as well as exercise performance, or influence health-
related, patient-centered factors.Patients and methods
Patients
Twenty-one patients with severe COPD participated in this
study (4f/17m; mean7standard deviation (S.D.) age 6579
years; 52724 packyears; forced expiratory volume in 1 s
(FEV1) 32.379.4% predicted; single breath diffusing capa-
city for carbon monoxide (DLCO) 43.2716.4% predicted;
body mass index (BMI) 25.974.7 kg/m2). Patients were
recruited from former in-patients of the hospital. Inclusion
required a stable state of the disease, the absence of
exacerbations within 2 weeks before, FEV1p50% pre-
dicted,15 agep80 years and 6-min walking distance
(6MWD)p500m. According to established criteria,16 11/10
patients had COPD stage III/IV. Medical treatment was
continued without change. Sixteen patients took inhaled
b2-adrenoceptor agonists, 21 anticholinergics, 10 theophyl-line, 7 inhaled corticosteroids and 11 used systemic
corticosteroids. Six patients had long-term oxygen therapy.
None of them showed airway diseases other than COPD or
diseases of the musculoskeletal system which would have
interfered with the training. The protocol had been
approved by the Local Ethics Committee and all patients
gave their written informed consent.
Study protocol
The study comprised two consecutive 2-week periods P1 and
P2, an initial visit V1 prior to P1, a home visit (H) at the last
day of P1, and a final visit V2 at the end of P2. At visit V1,
anthropometric data and clinical characteristics, 6MWD,
baseline values of lung function, and psychological and
quality-of-life scores were determined in the laboratory. At
visit V2, the same assessments were made as upon visit V1.
Assessments in the laboratory
Spirometry and bodyplethysmography (Masterlab, Viasys,
Wu¨rzburg, Germany) were performed following recommen-
dations.15,17 FEV1, vital capacity (VC), inspiratory capacity
(IC), intrathoracic gas volume (ITGV), residual volume (RV),
specific effective airway resistance (sReff), and DLCO were
assessed. 6MWD was determined in an exercise hall 3 to
account for learning effects. The three tests were separated
by at least 15min and the highest value was taken. Before
start and every minute until the end of the test patients
rated their dyspnea on a Borg scale to monitor the
development of symptoms with high resolution.
Quality of life was quantified by the SF-3618 and health-
related quality of life by the St. George’s Respiratory
Questionnaire (SGRQ).19–22 The baseline dyspnea index
(BDI) was assessed at V1 and the transition dyspnea index
(TDI)23 at V2.
Study periods at home
Daily activity was assessed during both 2-week periods. To
accommodate for scheduling difficulties, it was allowed to
vary the duration of periods by at maximum 5 days. The first
2-week period (P1) served for the assessment of normal
baseline activity, whereas the second period (P2) included
phone-controlled home-based training.
Training was designed as 3 daily 15min of raised
walking activity producing the dyspnea which had been
elicited at 75% of the individual 6MWD upon visit V1. It was
aimed to combine the walking as far as possible with regular
activities of daily life, thus facilitating its implementation.
Visit H served to briefly explore the individual environment
in order to advise the patient how to perform additional
activity most suitably and safely. Short phone calls were
included at days 2 and 7 of P1 to clarify potential problems
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Table 1 Results obtained in the laboratory at visit V1
prior to start of the control period P1 and at visit V2 after
A.R. Wewel et al.22regarding activity monitoring, and during P2 every other day
to motivate patients for training.the telephone intervention period P2.
V1 V2 p
FEV1 (L) 0.9470.29 1.0170.40 0.135
VC (L) 2.7570.93 2.8670.80 0.590
FEV1/VC (%) 34.875.0 35.377.6 0.876
IC (L) 2.0170.76 2.0670.70 0.651
ITGV (L) 5.8471.30 5.5871.20 0.068
RV (L) 5.0971.30 4.7771.20 0.073
sReff (cmH2O s) 46.6724.2 40.1719.4 0.015
6MWD (m) 379.67115.3 411.47100.5 0.030
Borg at rest score 2.071.3 2.371.4 0.135
Borg at the end of
walking score
3.971.7 4.171.5 0.717
BODE indexy score 3.471.4 2.971.4 0.012
BDI (V1)/TDI (V2) 5.072.1 2.072.5 0.001zDetermination of activity at home
Patients wore an electronic actograph at the right side of
their waist. The actograph stored three-dimensional move-
ments every minute (ActiTrac-Monitor, Somnomedics, Kist,
Germany). Movements were integrated into a count per
minute which was transferred to a computer for evaluation.
Side by side with the actograph patients wore a pedometer
(Kasper & Richter GmbH & Co. KG, Uttenreuth, Germany),
the readings of which were recorded in the diary. The
number of steps was converted into meters using the
individual length of stride. In the diary patients also
recorded the time per day of using pedometer and
actograph. Patients were instructed to wear these instru-
ments throughout the day from the morning until bedtime.sum score
SF-36 quality of life
Vitality score 45 (30; 55) 55 (40; 65) 0.030
Soc. act. score 63 (25; 88) 100 (63; 100) 0.005
Physical score 28 (25; 33) 28 (25; 39) 0.715
Psychol. score 47 (42; 54) 58 (52; 60) 0.017
SGRQ quality of life
Symptoms score 63 (54; 79) 68 (52; 79) 0.573
Activity score 79 (66; 93) 80 (66; 93) 0.717
Impacts score 46 (35; 54) 37 (21; 50) 0.149
Total score 59 (51; 64) 52 (45; 66) 0.322
Mean values7S.D. are given, or median values and quartiles
(in parentheses).Data analysis
Mean values and S.D. were computed. Analysis of covariance
(ANCOVA) was employed to assess the relationship between
variables taking into account the two study periods; the
corresponding correlation coefficients (R) thus reflected the
interdependence between data. Multiple linear regression
was used to estimate the impact of changes in one variable
on another one. For pairwise comparisons, the results of the
Wilcoxon test are reported, and for correlations those of
Spearman’s rank coefficient (rS). Statistical significance was
assumed for po0.05. Corrections for multiplicity were not
applied in this analysis.According to Wilcoxon matched-pairs signed-ranks test.
yTentatively obtained via proportional rescaling of the Borg
into the MMRC scale.
zReferring to TDI tested against zero by t-test.Results
All patients included did not experience an exacerbation of
their disease within 4 weeks prior to inclusion, and all
completed the study. As four patients experienced a
respiratory tract infection in period P, statistical analyses
were performed by either including (n ¼ 21) or excluding
(n ¼ 17) these patients to establish their influence on the
results.Comparison of visits V1 and V2
Among lung function variables only Reff showed a statisti-
cally significant change between visits V1 and V2 (Table 1).
6MWD was significantly increased by 31.8759.5m (mean7
S.D.) at visit V2 compared to V1 (n ¼ 21), while in patients
without exacerbation (n ¼ 17) 6MWD improved by 43.27
59.8m (p ¼ 0.011). Dyspnea at rest according to Borg did
not significantly differ between visits, but TDI assessed at V2
was different from zero. There were also significant changes
in the BODE index and the dimensions ‘‘vitality’’, ‘‘social
activity’’, and ‘‘psychological score’’ of the SF-36 ques-
tionnaire (Table 1). In contrast, the SGRQ did not show
statistically significant changes.Comparison of periods P1 and P2
Compared to period P1, total activity and activity per hour
were significantly raised in P2, regardless of whether
patients with an exacerbation in P2 were included or not
(Table 2). Total pedometer readings or readings per hour
showed a significant difference between periods only when
patients suffering from an exacerbation were excluded.
When the values declared as training in the diaries were
excluded from actograph or pedometer records, there
were no significant differences between periods P1 and P2
(Table 2). The time during which actograph and pedometer
were carried was also comparable in P1 and P2.
Relationship between variables and their changes
Total activity per hour as quantified by actograph was
correlated with total pedometer readings during periods
P1 and P2 (ANCOVA, R ¼ 0.55, po0.001; Figure 1).
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Table 2 Results obtained at home during the 2-week control period P1 and the 2-week intervention period P2.
P1 P2 p
All patients (n ¼ 21)
Duration of periodsy (days) 14.471.7 14.873.8 0.674
Duration of activity monitoring (days) 13.173.1 13.771.7 0.272
Electronic actograph
Total activity (counts) 192,6147127,247 235,4897116,953 0.017
Activity per hour of monitoring (counts/h) 10617636 13307726 0.007
Total activity without training (counts) 192,6147127,247 194,4767103,389 0.433
Pedometer and diary recording
Total pedometer reading (m) 31,215723,673 37,186720,341 0.079
Pedometer reading per hour (m/h) 1847119 2147121 0.140
Only patients without exacerbation during the study (n ¼ 17)
Electronic actograph
Total activity counts 152,306772,369 206,704785,197 0.013
Activity per hour (counts/h) 8547366 11557561 0.017
Pedometer and diary recording
Total pedometer reading (m) 27,309723,487 36,272719,590 0.019
Pedometer reading per hour (m/h) 1567106 2057109 0.049
In its upper part, the table presents data from all 21 patients, while in its lower part, data are given only for patients without
respiratory tract infection during the study (4 of the 21 patients experienced such an infection during the second study period, P2).
Mean values7S.D. are shown. Total activity and total pedometer readings were normalized to an observation period of 14 days
duration.
According to Wilcoxon matched-pairs signed-ranks test.
yNumber of days between visits V1 and H, or H and V2.
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Figure 1 Relationship between activity per hour as measured
by the actograph and pedometer readings per hour as
documented in the diary in period P1 (open circles) and period
P2 (closed circles).
Intervention by phone calls 23Furthermore, activity in P1 and P2 was related to 6MWD
assessed at V1 or V2 (R ¼ 0.49, po0.002; Figure 2).
Moreover, the change in 6MWD between V1 and V2 was
related to the change in activity per hour between P1 and P2
(rS ¼ 0.64, po0.003; Figure 3).
Due to the small number of patients, cross-sectional
correlation analyses were considered as only exploratory.
Although in univariate analyses, some variables were
correlated with 6MWD or activity, multivariate ANCOVA for
the identification of independent predictors revealed that
6MWD was consistently associated (po0.05) only with the
Borg score at rest (ANCOVA; Figure 4); there were, however,
no significant associations between the changes in activity
and the Borg score at rest. Activity, but not pedometer
distance, was weakly correlated (p ¼ 0.028) with sReff, as a
predictor showing fairly homogeneous distribution of values.
There were few correlations between the outcomes of
questionnaires and functional or activity measures, among
them a relationship between 6MWD and SGRQ ‘‘activity’’,
‘‘impacts’’, and ‘‘total’’ scores (po0.005 each) at visit 1,
but not at visit 2. At visit 2, there was a relationship
between the psychological score of the SF36 and 6MWD
(p ¼ 0.010).Discussion
The present study demonstrated that regular phone calls
were capable of raising domiciliary activity of patients withsevere COPD within 2 weeks to an extent that resulted in
increased exercise performance as measured by 6MWD. The
fact that pedometer records in the diary were correlated
with the electronic readings of the actograph (Figure 1)
indicated the validity of activity assessment and the quality
of diary entries. The scatter remaining is probably due to
the different modes of measurement.
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Figure 2 Correlation between activity per hour in periods P1
and P2, and 6MWD as determined at visits V1 and V2. Open
circles refer to P1 and V1, closed circles to P2 and V2.
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Figure 3 Relationship between the change in activity per hour
(P2P1) and the change in 6MWD (V2V1). Closed circles refer
to patients without exacerbation during the whole study
(n ¼ 17/21), while open triangles indicate the 4/21 patients
who experienced an exacerbation in period P2.
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Figure 4 Relationship between the Borg score at rest prior to
exercise tests and 6MWD as determined at visits V1 and V2.
Open circles refer to V1, closed circles to V2.
A.R. Wewel et al.24Our findings suggest that an increase in physical activity
per se can improve exercise performance within short time.
As the walking test was performed repeatedly at each visit,
it is unlikely that the gain in 6MWD was due to increased
skills to master the test. In fact, the correlation between
the change in activity and that of 6MWD (Figure 3) strongly
suggests that the rise in activity was responsible for that of
exercise performance. As patients were included at least 4
weeks after discharge from the hospital (most of them
considerably later), it is unlikely that the improvement
observed was due to ongoing recovery from previous
deteriorations. It also seems noteworthy that in the phone
contacts patients reported enthusiastically about their
activity on the respective days.
Four patients experienced a respiratory tract infection
during the intervention but not the control period. The
overall frequency of exacerbations was thus 1 per 21 patient
weeks and well within the range expected. We kept these
patients in the analysis, as they demonstrated that a lack of
increase in activity was associated with a lack of gain in
6MWD and that not the phone contact per se but the
resultant training was important. This seems to be a
particularly noteworthy finding as we did not include a
control group in the present study. These patients also
underlined that the improvement observed in the group was
not due to unrealistic inclusion criteria by neglecting
frequent clinical events in severely ill patients.
Correlations between 6MWD or activity and pulmonary
function were not very stable from a statistical point of
view, due to collinearity and the sensitivity to outliers in the
small population studied. However, those correlations which
were consistent in multivariate analyses were also plausible,
such as that between activity or 6MWD and airway
resistance. Changes in lung function were minor and
possibly the result of the patients’ better compliance
to therapy, though we were not able to verify this. When
using the reduction in sReff and the (cross-sectional)
regression relating sReff and 6MWD, only a minor fraction
of the gain in 6MWD could be formally attributed to
sReff. Similar results were obtained for other indices of
lung function, as well as for activity. This supports the
assertion that functional changes played no role in the rise
in activity which then caused the increase in exercise
performance.
Daily activity in severe COPD is probably the result of
long-term adaptation reflecting a balance between physical
abilities, personality traits, and opportunities provided by
the environment. The importance of motivation has been
underlined by recent findings on the positive effects of a
lifestyle counselling programme during pulmonary rehabili-
tation.24 The reverse approach of raising activity by
improving exercise capacity cannot be tested from our
data. It possibly requires further action for motivating
patients to utilize the additional capacity, such as participa-
tion in rehabilitation programmes.13
Indeed, a previous study involving hospital-based train-
ing13 provided evidence that patients increased their
activity also in the time not devoted to training. Probably
the patients’ motivation was higher in the hospital than at
home, as in the present study there was no rise in activity
when the time reported as training by the patients was
excluded. Irrespective of this, 6MWD was raised and the
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Intervention by phone calls 25improvement in SF-36 scores indicated that patients felt an
overall benefit.
On average, the level of activity observed at baseline
appeared to be in the range reported in the literature.25
Moreover, in accordance with previous observations,13
interindividual variation was large and activity was mainly
associated with 6MWD (Figure 2). Correlation was not
improved by introducing the product of 6MWD and BMI
(6MWORK) as an adjusted measure of exercise capacity.26
6MWD also correlated with the Borg score at rest (Figure 4),
as shown before,14 and a tentative factor analysis of the
present data confirmed the previous findings (results not
shown). Though the association between dyspnea and 6MWD
has not been verified by all investigators,27 it is possible to
raise exercise capacity by increased tolerance to dyspnea.
There was, however, no evidence for this in our study and in
a multivariate regression analysis the relationship between
the changes in activity and 6MWD did not depend on dyspnea
scores. Corresponding to dyspnea scores, there were
correlations between disease-specific SGRQ scores and
6MWD at baseline which disappeared at the second visit;
instead, a correlation of 6MWD with the SF-36 psychological
score emerged, supporting the role of generic psychological
factors for activity and training.
The findings obtained by directly measuring activity are in
accordance with those of an activity score assessed before
and after pulmonary rehabilitation.28 To compute the BODE
index29 as a comprehensive measure of risk and severity in
COPD, we tentatively rescaled the Borg into the MMRC
dyspnea scale by proportional scaling. The BODE index thus
computed showed a reduction after intervention in eight
patients and was unchanged in the others. Activity was
correlated with the BODE score to the same degree as with
6MWD alone. Thus, individual activity in severe COPD
seemed to be primarily related to 6MWD, but not or to a
lesser degree to other measures, in accordance with
previous results.30,31 It should be noted that we used
activity only for monitoring motivational efficacy. To
establish activity as an independent outcome measure
probably requires study designs involving the determination
of exacerbation and mortality rates as clinical endpoints.12
Our study aimed at implementing a minimally expensive
intervention. To assess the potential inherent to our
approach, we included frequent phone calls, as well as an
initial and final visit at the laboratory and a brief home visit
to inspect the patients’ opportunities for increasing activity.
As patients wore activity monitors and pedometers through-
out the study, it is unlikely that these have led to the
observed increase in activity during the second study period.
Available evidence also suggests that the mere presence of
such equipment does not modulate activity.32 It is therefore
likely that the phone calls have indeed raised activity.
It is not clear whether less interventional action would
have led to the same result. Previous data suggested that
even minimal contacts, at about every 3 months, were
capable of maintaining benefits after hospital-based initia-
tion of training.3,5 The phone calls which had a duration of
about 10min each were considered as personal care by the
patients and involved explicit motivation for training. It
seems currently questionable that automatic call centers
will markedly simplify the procedure, as many patients
probably need to be contacted by a human being, whichcannot be delegated to a computer. Future studies will have
to assess how to implement a minimal but still effective
programme and how to maintain the improvement in
activity with minimal effort, such as phone calls at lower
frequency, over prolonged periods of time. The present trial
was designed as a proof-of-concept study that covered a
period of time as short as possible to reduce the impact of
exacerbations. This also implied the non-randomized design,
with the control period followed by the intervention period
to avoid carry-over effects. As a perspective, participation
in a short and simple programme such as the present one
might also be helpful for predicting an individual’s success in
a long-term intervention. Furthermore, the applicability of
our approach does not seem to be limited to COPD or to
require the absence of comorbidities which we kept minimal
in our small group of patients.
In conclusion, the present data demonstrate that in
patients with severe COPD daily activity at home could be
raised by initiation of regular phone calls. Within 2 weeks,
this led to an increase in 6MWD which was correlated with
that of activity. These findings underline the effectiveness of
motivational support for improving the functional, and
possibly also clinical, state in patients with severe COPD.
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